Detailed Narrative
Strong Q2 Performance and Raised Full-Year Outlook
Church & Dwight reported a strong second quarter, with net sales increasing 1.6% and organic sales growing 5.8%, significantly surpassing the 3% outlook. This growth was broad-based across all three divisions, driven primarily by 4.3% volume growth and 1.5% positive price/mix. Adjusted gross margin improved by 40 basis points to 45.4%, and adjusted EPS of $0.89 exceeded the $0.88 outlook. The robust first-half performance led the company to raise its full-year outlook for sales, EPS, and cash flow, reflecting confidence in continued momentum.
Strategic Acquisitions and Innovation Driving Growth
The company completed the acquisition of the Missmouth brand in June, which is already showing strong initial sales results, with consumption growing over 50% and gaining 3.5 share points. Management sees significant growth opportunities for Missmouth due to its low household penetration (2.5% vs. 50% category) and ACV (35% vs. 80% category). Innovation and distribution gains remain key competitive advantages, with new product launches expected to contribute about half of the organic growth this year across various categories.
Key Brand Momentum and Market Share Expansion
Several power brands demonstrated strong performance and market share gains. THERABREATH mouthwash achieved record share gains, jumping 4.5 points to 25.3% and solidifying its #2 position, with household penetration still low at 14% compared to the 65% category average. The THERABREATH toothpaste launch is also performing well, securing a 1 share point in total toothpaste. ARM & HAMMER Cat Litter consumption grew 7.5%, increasing its share by 0.8 points to 2.5. Hero continues to outpace the acne patch category, with its new cleanser launch and low household penetration (10% vs. 30% category) indicating further growth potential.
International and E-commerce as Growth Engines
The international business delivered a strong 9.1% organic sales growth, driven by higher volume and favorable price mix, with growth outpacing local GDPs. U.S. acquisitions like Hero and THERABREATH are driving outsized growth globally, demonstrating the company's ability to scale brands quickly across many countries. Global e-commerce also continued its strong contribution, growing 22.7% in the second quarter and now accounting for 25.5% of total consumer sales.
Cost Management, Reinvestment, and Future Optimism
Despite facing approximately $30 million in transitory📎 cost pressures from raw materials, transportation, and Middle East conflict-related premiums, the company has mitigated these through increased productivity. Management plans to invest an expected $15 million from Phase 2 tariff refund benefits into consumer-facing activities and increase marketing spend to at least 11% of sales. The CEO expressed strong optimism for the future, citing ongoing category work for ARM & HAMMER, acceleration plans for oral care, and a practical international M&A pipeline, with a detailed update expected in early 2027.